Rare diseases
Investigational molecules
Locations
353 conditions with trials, the busiest first
844 trials across Europe, recruiting first
Study on Pembrolizumab for Patients with High-Risk Melanoma Without Signs of Metastasis
BelgiumStudy on [68Ga]Ga-FAPI-46 and Fludeoxyglucose (18F) PET/CT Imaging for Evaluating Treatment Response in Patients with Advanced Malignant Melanoma
DenmarkStudy on Stopping Nivolumab or Pembrolizumab in Advanced Melanoma Patients After Achieving a Response
The NetherlandsStudy on the Effectiveness and Safety of Ianalumab for Patients with Diffuse Cutaneous Systemic Sclerosis
AustriaStudy of TIL therapy combined with peginterferon alfa-2a and nivolumab for patients with metastatic melanoma
The NetherlandsStudy of nivolumab and ipilimumab combination therapy as an alternative to surgery and radiation in patients with skin squamous cell carcinoma
The NetherlandsStudy of MC2 TCR T Cell Therapy and Epigenetic Drug Treatment for Patients with Advanced Melanoma or Head and Neck Cancer
The NetherlandsStudy on Using Perflubutane for Sentinel Node Detection in Patients with Breast Cancer, Melanoma, or Head and Neck Cancer
The NetherlandsStudy on Early Treatment of Plaque Psoriasis with Bimekizumab and Clobetasol Propionate for Patients with Chronic Inflammation
FranceStudy on the Safety of TOP-N53 for Treating Digital Ulcers in Systemic Sclerosis Patients
FranceStudy on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors
BelgiumStudy on the Effects of Rituximab and Obinutuzumab in Patients with Systemic Lupus Erythematosus (SLE)
The NetherlandsThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
